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Abstract
Background: Recently there has been a large outbreak of Zika virus infections in Colombia, South America. The
epidemic began in September 2015 and continued to April 2017, for the total number of Zika cases reported of
107,870. For those confirmed Zika cases, there were nearly 20,000 (18.5%) suspected to be pregnant women,
resulting in 157 confirmed cases of microcephaly in newborns reported by their health government agency. There
is a clear under-estimation of the total number of cases and in addition no prior publications have been published
to demonstrate the clinical aspects of the Zika infection in Colombia. We characterized one Zika presentation to be
able to compare and contrast with other cases of Zika infection already reported in the literature.
Case presentation: In this case report, we demonstrate congenital microcephaly at week 19 of gestation in a
34-year-old mother who showed symptoms compatible with Zika virus infection from Sincelejo, State of Sucre, in
the Colombian Caribbean. Zika virus RNA was detected in the placenta using real-time reverse transcriptase
polymerase chain reaction (RT-PCR). At week 25, the fetus weigh estimate was 770 g, had a cephalic perimeter of
20.2 cm (5th percentile), ventriculomegaly on the right side and dilatation of the fourth ventricle. At week 32, the
microcephaly was confirmed with a cephalic perimeter of 22 cm, dilatation of the posterior atrium to 13 mm, an
abnormally small cerebellum (29 mm), and an augmented cisterna magna. At birth (39 weeks by cesarean section),
the head circumference was 27.5 cm, and computerized axial tomography (Siemens Corp, 32-slides) confirmed
microcephaly with calcifications.
Conclusion: We report a first case of maternal Zika virus infection associated with fetal microcephaly in Colombia
and confirmed similar presentation to those observed previous in Brazil, 2015–2016.
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Background
Zika, Chikungunya and dengue viruses are tropical vec-
tor borne viral diseases that are all endemic in
Colombia, South America. During the last 16 months,
Colombia has experienced a large outbreak in Zika in-
fection. From September 2015 through May 20th 2017,
107,870 reported cases. However, only 9.5% of these
were laboratory confirmed at the Colombian National
Institute of Health (INS) [1, 2]. Infection with Zika virus
during pregnancy has been linked to the occurrence of
microcephaly via transplacental infection of the develop-
ing fetus and subsequent neuronal cell death. In South
America, the Zika virus outbreak began in Brazil in May
2015, and in Colombia local transmission, began about
5 months later, in October 2015. The disease has spread
to the entire country where Aedes aegypti is as well
established vector. Similar to other countries in the
Americas affected by Zika virus, the increases of con-
genital syndromes including microcephaly cases and
Guillan Barre syndrome appeared abruptly coincident
with the Zika virus disease (ZVD) outbreak. In 20 May
2017, there was a calculation of 0.22% of Colombian
population that has been affected by ZVD including al-
most 20,000 cases of infected pregnant women [2]. This
is an alarming situation because of congenital defects as-
sociated with ZIKV infection. Such congenital defects
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cases have increased since 2016 [1–3]. The number of
cases confirmed in laboratories is lower (9.7%) than re-
ported in other countries [3, 4]. Most cases confirmed in
laboratories correspond to those notified in pregnant
women (64.95%). Currently, the Instituto Nacional de
Salud of Colombia (INS) continues active surveillance
for birth defects, including microcephaly [2–4]. Up to
date, in Colombia, there is no published report of micro-
cephaly associated with Zika virus infection. We report
here a case of microcephaly in a child exposed in utero
via maternal infection with Zika virus.
Case presentation
We describe a case of microcephaly associated with Zika
virus infection in an infant born on 17 July 2016. The 34-
year-old mother showed symptoms compatible with Zika
infection: rash at week 19 of gestation, living in an en-
demic area during the last 5 years and with no immuno-
deficiency or autoimmune diseases. Laboratory tests
showed no evidence of diabetes or blood-pressure-related
disorders. In her medical history, the mother indicated no
drug or alcohol use or smoking during pregnancy. No ac-
tive infection against toxoplasma, rubella, cytomegalo-
virus, herpes, syphilis, Chikungunya, dengue, and human
immune deficiency virus (HIV) was detected in the
mother’s serum as per Hospital laboratory testing report.
At 16 weeks, ultrasound showed a head circumference
of 11.5 cm and fetal weight estimate of 219 g. At
25 weeks, the fetus weight was 770 g, with a cephalic
perimeter of 20.2 cm (5th percentile), ventriculomegaly
on the right side and dilatation of the fourth ventricle. A
third ultrasound at week 32 showed a cephalic perimeter
of 22 cm and confirmed the microcephaly diagnosis with
dilatation of the posterior atrium to 13 mm, an abnor-
mally small cerebellum (29 mm), and an augmented
cisterna magna. At birth, the anterior fontanelle was
closed; the facies were symmetrical; normal ocular aper-
tures; normal spleen and urinary size determined via
ultrasound; good respiratory pattern; normal palate; nor-
mal heart rate with no alterations and no megalia de-
tected. At birth (39 weeks by cesarean section), the
infant’s head circumference was 27.5 cm and the com-
puterized axial tomography scan confirmed microceph-
aly with calcifications (Fig. 1).
Zika virus RNA was extracted using standard proce-
dures from the placenta, Zika genome was detected in
the placenta using real-time reverse transcriptase poly-
merase chain reaction (RT-PCR) according to Zika spe-
cific PCR previously published [4–6]. Detection of Zika
virus in umbilical cord and serum of the neonate via RT-
PCR were unsuccessful. We utilized the commercial
Zika virus test (Biocan, Canada). IgM antibodies to Zika
were detected in the serum of the mother. Currently, the
newborn is 9 months old with strabismus, weak muscle
tone in his neck, recurrent neurological cry, repeated
respiratory infections, neurological impairment and pos-
sibly normal hearing (data no published).
Discussion
We report a first case in Colombia of fetal Zika virus in-
fection via maternal transmission resulting in microceph-
aly. It is important to note that during the previous five
years the mother lived in Sincelejo, Sucre State, an en-
demic area for Zika in the Colombian Caribbean. As re-
ported by the INS, Zika virus has presumably infected
more than 1655 cases in Sucre State, representing 1.53%
of the total Colombian population, this data would con-
firm the high prevalence of Zika in the area where the
clinical case derives from. Since the Zika outbreak began
in Colombia neurologic anomalies including microcephaly
157 accumulated total cases have been reported to the
INS [1, 2]. The data illustrate the large epidemiologic im-
pact of Zika virus infection on the population of Sucre
state. In the present report, Zika viral RNA was detected
in the placenta by RT-PCR and IgM antibodies to Zika
were detected in the mother’s serum. It is not known
exactly how Zika virus reaches the embryo, but it remains
in the placenta until delivery and presumably crosses to
the fetus from the placenta [6]. However, there are reports
of RNA being found in symptomatic pregnant women up
to 53 days after initial symptoms [6].
Fig. 1 a Intracebral calcifications of the congenital prenatal
infectious type. b Cerebral hypoplasia. c Microcephaly. d
Supratentorial hydrocephalus. CAT was carried out using axial cuts
from the base to convexity. CAT scan shows: brain size diminished
with deformity with evidence of congenital microcephaly. Cerebral
parenchyme volume is diminished due to hypoplasia associated to a
ventricular dilated suparatentorial. Amplitude of the furrows and
intraparenchymal cortical calcifications by malformation and
subarachnoid spaces, there is no displacement of midline structures,
brain stem and cerebellum are preserved
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During pregnancy, infection with Zika virus has been
associated with microcephaly and other fetal brain ab-
normalities [7–10]. The first ultrasound detection of
fetal brain abnormalities associated with Zika virus var-
ies from between 20 and 40 weeks of gestation [3, 7, 8].
In the present study abnormalities were confirmed at
25 weeks. In Brazil investigators, observed abnormalities
at early as 21 weeks of gestation [3, 9]. Although micro-
cephaly was confirmed by ultrasonography at week 25,
the mother decided not to interrupt her pregnancy. This
decision was likely related to religious and cultural be-
liefs of many Colombian women who would prefer to
completion of the pregnancy, Brazilian investigators have
established a range 8–35 (mean = 27.8) weeks of gesta-
tion as being critical for Zika related microcephaly, dem-
onstrating the criticality of infection during the 1st and
2nd trimesters for fetal brain abnormalities to be ob-
served [8]. The diagnosis of our case at week 25 of gesta-
tion is in agreement with the Brazilian findings [8].
Further, we have observed two newborn babies affected
with Dandy Walker syndrome associated with Zika virus
infection (data no published).
Between 2010 and 2017, neurologic complications
(microcephaly) in French Polynesia Brazil and Colombia
have increased dramatically [4, 5, 9, 10]. These brain
malformations in those countries coincided with Zika
virus outbreaks [10–12]. The relationship between Zika
virus and microcephaly was first suspected in Brazil in
2015. Based on a retrospective study in French Polynesia
and the new emerging public health problem in Brazil,
the Pan American Health Organization declared an alert
on 17 November 2015 [7]. In January 2016, Brazil re-
ported 3893 cases of microcephaly. In February 2016,
the World Health Organization declared a global health
emergency [7]. In the Colombian public health system,
declaration of microcephaly cases was not obligatory but
the currently identified cases Zika-associated microceph-
aly confirm the need for increased vigilance and moni-
toring. In Colombia, before the current thrush of
microcephaly cases appeared, an etiologic relationship
between Zika virus and microcephaly was not suspected
and a relationship between Zika virus and central ner-
vous system anomalies was doubted.
The 19,935 cases of pregnant women with clinically com-
patible Zika virus infection suggest that Colombia may
experience a dramatic increase in the number of micro-
cephaly cases. Out of a total of 19,935 pregnant women,
157 (0.79%) cases of congenital microcephaly associated
with Zika virus infection have been reported; it is unknown
whether this number will increase in the near future. It is
also unknown the reasons why some pregnant women in-
fected by Zika virus give birth to healthy babies and others
do not. Individual genetic background or modulation of the
immune system can perhaps be involved in the pathways
for the virus to reach trophoblasts. In Colombia, before
microcephaly cases appeared, an etiologic relationship be-
tween Zika virus and microcephaly was not demonstrated
and a relationship between Zika virus and central nervous
system anomalies was doubted.
In the Colombian Caribbean, we have witnessed an in-
crease in microcephaly associated with Zika virus preva-
lence and exposure during pregnancy [2–4]. Some of the
exposed mothers will be delivering their babies during
the next four months, and our current research suggests
that the number of fetal microcephaly cases will in-
crease. Unfortunately, it is too soon to establish the
exact incidence of microcephaly in the already pregnant
women in Colombia. Brazilian officials have detected
fetal abnormalities in 12/42 (29%) of Zika virus-positive
women, but we do not know whether this rate will be
similar in Colombia [4, 7, 9]. The cost of treatment to
improve neurodevelopmental deficiencies in children
due to Zika mediated neuronal cell death remains a
major concern for Colombia. Early and low-cost sero-
diagnosis of Zika virus infection will be critical to avoid
high degrees of unseen consequences to viral infection.
Serologic detection of Zika is problematic in Colombia
and Latin-American due to cross virus reactivity in
current imuno-assays. Besides the ordinary screening
tests (toxoplasma, rubella, cytomegalovirus, herpes,
syphilis and HIV) the Colombian Minister of Health
must quickly ensure that pregnant women be aware of
and be protected against new agents such Zika, also, bet-
ter characterized viruses like Chikungunya and Dengue
must be included in any viral screening that for the past
or present invasion of a viral mediated congenital defect
such as microcephaly. All inborn errors of cell function
present a significant weight on current drug develop-
ment, with many effective therapies being too expensive
to be developed. We have significant economic progress
to make ensure that the impact of our public health
measure be maximized.
Conclusions
Here, we report the for the first time a case in Colombia,
South America of fetal microcephaly associated with ma-
ternal Zika virus infection. There have been 19,935 sus-
pected cases of Zika infection of pregnant women in
Colombia and these numbers must with a relatively
small number (n = 157) associated with fetal microceph-
aly (0.79%). Zika virus related microcephaly needs to be
monitored closely in those countries experiencing out-
breaks so as to provide accurate information on risk to
the unborn fetus. The experience in Colombia as well as
other countries provides an important epidemiologic ex-
ample to predict risk for other countries. This and other
reports provide critical information for world medical
and community public health.
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